Transition Bio | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,655 results for “Transition Bio”

Trials

View all 3953 →

Active, not recruiting

TransitionCHF Systolic Dysfunction to Congestive Heart Failure Cohort Study

1,000 participants · First posted Dec 23, 2014

Bone Volume Changes After Socket Preservation Using Geistlich Bio-Oss Collagen and Mucograft Seal

30 participants · First posted Jan 10, 2018

Transition of Diabetes Care From Pediatric to Adult Healthcare Providers.

55 participants · First posted Feb 18, 2019

Drugs

View all 1043 →

DMPK RNA+MBNL1 Targeted therapy(Transition Bio)

MYC RNA+YTHDC1 Targeted therapy(Transition Bio)

S 7 (Transition Therapeutics)

Organizations

View all 274 →

Transition Therapeutics Ireland Ltd.

Ireland

BIO-RAD

France

Akamis Bio

United Kingdom

News

View all 3385 →

Transition Bio and Voyager Therapeutics Partner to Develop Small Molecule TDP-43 Inhibitors for ALS and Frontotemporal Dementia

Voyager Therapeutics Advances Multi-Modal Neurotherapeutics Pipeline with Novel NeuroShuttle Platform and TDP-43 Collaboration

CVS Health Drops J&J's Stelara from Main Formularies in Favor of Lower-Cost Biosimilars

Page 1 of 866